4//SEC Filing
Santos da Silva Jorge 4
Accession 0001213900-25-120106
CIK 0001821586other
Filed
Dec 9, 7:00 PM ET
Accepted
Dec 10, 4:29 PM ET
Size
7.0 KB
Accession
0001213900-25-120106
Insider Transaction Report
Form 4
Santos da Silva Jorge
DirectorChief Executive Officer
Transactions
- Sale
Class A ordinary shares, par value $0.0001 per share
2025-12-08$15.08/sh−130,000$1,960,400→ 2,948,577 total - Sale
Class A ordinary shares, par value $0.0001 per share
2025-12-09$14.49/sh−70,000$1,014,300→ 2,878,577 total
Footnotes (2)
- [F1]Sales made pursuant to Rule 144 under the Securities Act of 1933, as amended, to cover tax liabilities of the Reporting Person and other expenses incurred related to the sales.
- [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $15.045789 to $15.098641. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001920509
Filing Metadata
- Form type
- 4
- Filed
- Dec 9, 7:00 PM ET
- Accepted
- Dec 10, 4:29 PM ET
- Size
- 7.0 KB